Literature DB >> 11941936

Prevalence of Helicobacter pylori in the residual stomach after gastrectomy for gastric cancer.

Takao Katsube1, Kenji Ogawa, Kanako Hamaguchi, Minoru Murayama, Soichi Konnno, Takeshi Shimakawa, Yoshihiko Naritaka, Hirokazu Yagawa, Tetsuro Kajiwara, Motohiko Aiba.   

Abstract

BACKGROUND/AIMS: In recent years, the role of Helicobacter pylori in gastritis of the residual stomach has attracted much attention. We investigated the prevalence of Helicobacter pylori in the residual stomach after distal gastrectomy for gastric cancer, as well as the correlations between Helicobacter pylori positivity and clinical characteristics or the severity of gastritis in the residual stomach.
METHODOLOGY: The subjects were 66 patients with gastric cancer who underwent distal gastrectomy with Billroth I reconstruction at our department. Helicobacter pylori was detected by the 13C-urea breath test, and patients were considered to be Helicobacter pylori-positive if the delta 13C value was > 2.5@1000.
RESULTS: The overall Helicobacter pylori positivity rate of the gastrectomy patients was a high 80.3%, with the rate being especially high in patients under 60 years of age and in those tested less than 5 years after surgery. There was a close relationship between Helicobacter pylori positivity and the severity of gastritis.
CONCLUSIONS: Helicobacter pylori infection appears to cause the development of gastritis. Helicobacter pylori eradication needs to be taken into consideration in the management of Helicobacter pylori-positive patients after gastrectomy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11941936

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

Review 1.  Helicobacter pylori infection following partial gastrectomy for gastric cancer.

Authors:  Sanghoon Park; Hoon Jai Chun
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Interleukin-8, cyclo-oxygenase-2, and trefoil factor family 1 gene expression and their association with Helicobacter pylori infection in the remnant stomach.

Authors:  Chengzhong Xing; Shunji Kato; Norio Matsukura; Noriko Matsuda; Huimian Xu; En Takashi; Nobutaka Yamada; Zenya Naito; Takashi Tajiri
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Correlation between the current TNM staging and long-term survival after curative D1 lymphadenectomy for stomach cancer.

Authors:  Saleh M Abbas; M W Booth
Journal:  Langenbecks Arch Surg       Date:  2005-01-15       Impact factor: 3.445

4.  Evaluation of the efficacy of triple therapy regimen for Helicobacter pylori eradication in gastrectomized patients with gastric adenocarcinoma.

Authors:  Jose Luiz Bertoli Neto; Laercio Gomes Lourenço; Cícero Fernando Bertoli; Fábio Samsonowski Ulbrich; Antoninho Ricardo Sabbi; Alexandre Galvão Bueno
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

5.  Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication.

Authors:  K Hamaguchi; K Ogawa; T Katsube; S Konno; M Aiba
Journal:  Langenbecks Arch Surg       Date:  2004-02-06       Impact factor: 3.445

Review 6.  Role of New Anatomy, Biliopancreatic Reflux, and Helicobacter Pylori Status in Postgastrectomy Stump Cancer.

Authors:  Luigi Basso; Gaetano Gallo; Daniele Biacchi; Maria Vittoria Carati; Giuseppe Cavallaro; Luca Esposito; Andrea Giuliani; Luciano Izzo; Paolo Izzo; Antonietta Lamazza; Andrea Polistena; Mariarita Tarallo; Alessandro Micarelli; Enrico Fiori
Journal:  J Clin Med       Date:  2022-03-09       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.